E
About
Ernst Geutjes is a Venture Partner at Aglaia Oncology Funds. Aglaia invests in oncology drug development companies and has a proven ability to select and mature early-stage breakthrough inventions that have the potential to transform cancer treatment. The Aglaia team has decades of experience in cancer research and oncology drug development. Since 2004, Aglaia has built an excellent reputation in starting up biotech companies that focus on oncology drug development.
Focus Areas
BioTech, Oncology
Verified Contact & Outreach Agent
Direct Professional Email Pattern
AI Outreach Agent Pitch Writer
Compose an personalized, high-converting outreach message targeting their exact investment interest...